(1)(1)(a) Except in the case where parents object on the grounds that they are members of a specified, well-recognized religious organization whose teachings are contrary to the tests required by this section, a newborn infant shall be tested for:
(1)(a)(i) phenylketonuria (PKU);
(1)(a)(ii) other heritable disorders which may result in an intellectual or physical disability or death and for which:
(1)(a)(ii)(A) a preventive measure or treatment is available; and
(1)(a)(ii)(B) there exists a reliable laboratory diagnostic test method;
(1)(a)(iii) hearing loss; and
(1)(a)(iv) critical congenital heart defects using pulse oximetry.
(1)(b) (1)(b)(i) Prior to conducting newborn infant testing under this section, information shall be provided to the newborn infant's parent or guardian explainin
Free access — add to your briefcase to read the full text and ask questions with AI
(1) (1)(a) Except in the case where parents object on the grounds that they are members of a specified, well-recognized religious organization whose teachings are contrary to the tests required by this section, a newborn infant shall be tested for:
(1)(a)(i) phenylketonuria (PKU);
(1)(a)(ii) other heritable disorders which may result in an intellectual or physical disability or death and for which:
(1)(a)(ii)(A) a preventive measure or treatment is available; and
(1)(a)(ii)(B) there exists a reliable laboratory diagnostic test method;
(1)(a)(iii) hearing loss; and
(1)(a)(iv) critical congenital heart defects using pulse oximetry.
(1)(b) (1)(b)(i) Prior to conducting newborn infant testing under this section, information shall be provided to the newborn infant's parent or guardian explaining relevant facts and information about newborn infant testing and sample storage under this section.
(1)(b)(ii) Prior to conducting a newborn infant heelstick screen under this section, a copy of the privacy consent form described in Subsection (5) shall be provided to the newborn infant's parent or guardian.
(1)(b)(iii) The department may retain, in accordance with the department's retention policy, a biological sample and any genetic data, as those terms are defined in Section 13-60-102, collected under this section, only if a parent or guardian consents to the retention policy on the privacy consent form.
(1)(c) A biological sample and any genetic data collected under this section shall be destroyed:
(1)(c)(i) according to the department's retention policy; or
(1)(c)(ii) if the newborn infant's parent or guardian does not consent to the department's retention policy, upon completion of the newborn infant's testing under this section.
(2) In accordance with Section 26B-1-209, the department may charge fees for:
(2)(a) materials supplied by the department to conduct tests required under Subsection (1);
(2)(b) tests required under Subsection (1) conducted by the department;
(2)(c) laboratory analyses by the department of tests conducted under Subsection (1); and
(2)(d) the administrative cost of follow-up contacts with the parents or guardians of tested infants.
(3) Tests for hearing loss described in Subsection (1) shall be based on one or more methods approved by the Newborn Hearing Screening Committee created in Section 26B-1-432, including:
(3)(a) auditory brainstem response;
(3)(b) automated auditory brainstem response; and
(3)(c) evoked otoacoustic emissions.
(4) Results of tests for hearing loss described in Subsection (1) shall be reported to:
(4)(a) the department; and
(4)(b) when results of tests for hearing loss under Subsection (1) suggest that additional diagnostic procedures or medical interventions are necessary:
(4)(b)(i) a parent or guardian of the infant;
(4)(b)(ii) an early intervention program administered by the department in accordance with Part C of the Individuals with Disabilities Education Act, 20 U.S.C. Sec. 1431 et seq.; and
(4)(b)(iii) the Utah Schools for the Deaf and the Blind, created in Section 53E-8-201.
(5) The department shall publish a privacy consent form containing:
(5)(a) relevant facts and information about:
(5)(a)(i) the purposes for which the department retains biological samples or any genetic data obtained through newborn infant testing; and
(5)(a)(ii) the department's retention policy for biological samples or any genetic data obtained through newborn infant testing; and
(5)(b) the option for a parent or guardian to indicate consent to the department's retention policy.